← All trials
NCT03830398
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 20, 2018
- Primary completion
- May 31, 2019
- Completion date
- Jun 30, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 225
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Mustafa Kemal UniversityLead sponsor
- Mustafa Kemal UniversityReponsible party - principal investigator
- Mustafa Kemal UniversityStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.